HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

safinamide

short-acting inhibitor of MOA-B; FCE 26743 is (S)-isomer, FCE 28073 is (R)-isomer; structure in first source
Also Known As:
(S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide; 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide; FCE 26743; FCE 28073; FCE-26743; FCE-28073; NW-1015; PNU 151774E; PNU-151774E; Xadago; fbap methanesulfonate; safinamide methanesulfonate
Networked: 158 relevant articles (44 outcomes, 62 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cattaneo, Carlo: 8 articles (01/2021 - 01/2015)
2. Kulisevsky, Jaime: 7 articles (02/2022 - 02/2017)
3. Müller, Thomas: 7 articles (01/2020 - 09/2013)
4. Tsuboi, Yoshio: 6 articles (03/2022 - 01/2020)
5. Pagonabarraga, Javier: 6 articles (01/2022 - 10/2019)
6. Sardina, Marco: 6 articles (01/2018 - 01/2013)
7. Hattori, Nobutaka: 5 articles (03/2022 - 01/2020)
8. Nomoto, Masahiro: 5 articles (03/2022 - 01/2020)
9. Stocchi, Fabrizio: 5 articles (02/2022 - 01/2012)
10. Caccia, Carla: 5 articles (08/2021 - 01/2018)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Dyskinesias (Dyskinesia)
3. Pain (Aches)
4. Tremor (Tremors)
5. Hypokinesia (Bradykinesia)

Related Drugs and Biologics

1. Levodopa (L Dopa)
2. Monoamine Oxidase (MAO)
3. Glutamic Acid (Glutamate)
4. Dopamine (Intropin)
5. safinamide
6. rasagiline (Azilect)
7. Dopamine Agonists (Dopamine Agonist)
8. Sodium Channels (Sodium Channel)
9. Mesylates (Mesylate)
10. pardoprunox

Related Therapies and Procedures

1. Therapeutics
2. Deep Brain Stimulation
3. Investigational Therapies (Experimental Therapy)
4. Oral Administration
5. Aftercare (After-Treatment)